About the Ocular Melanoma Treatment Session
Ocular melanoma, a rare malignancy in the eye's melanocytes, demands a comprehensive treatment strategy. Early diagnosis is vital for successful intervention. Treatment modalities include surgical excision, radiation therapy, and laser treatment. Enucleation, the removal of the eye, is considered for advanced stages where vision preservation is unfeasible. Brachytherapy, involving localized radiation, focuses on the tumor while preserving adjacent tissues. Proton beam therapy provides precise radiation targeting, reducing damage to essential ocular structures. Emerging treatments like immunotherapy and targeted drug therapies offer promising adjunctive options. Continuous monitoring and follow-up are critical to identify recurrences or metastasis, ensuring holistic management of ocular melanoma patients.
Topics Covered in Ocular Melanoma Treatment
Plaque Brachytherapy
Proton Beam Therapy
Enucleation
Local Tumor Resection
Transpupillary Thermotherapy
Tebentafusp & Immunotherapy
Related Scientific Sessions at IOC 2027
Why Attend the Ocular Melanoma Treatment Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Ocular Melanoma Treatment work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Ocular Melanoma Treatment research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Ocular Melanoma Treatment track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ocular Melanoma Treatment Conference 2027 — FAQs
What is the Ocular Melanoma Treatment track at IOC 2027?
The Ocular Melanoma Treatment track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ocular Melanoma Treatment. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ocular Melanoma Treatment sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ocular Melanoma Treatment are all welcome — whether presenting or attending.
Can I present my research in the Ocular Melanoma Treatment track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ocular Melanoma Treatment sessions?
Yes. IOC 2027 is a hybrid conference — attend the Ocular Melanoma Treatment track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.